Procalcitonin Is a Prognostic Marker of Hospital Outcomes in Patients with Critical Limb Ischemia and Diabetic Foot Infection
Aim. To evaluate the prognostic role of procalcitonin (PCT) in patients with diabetic foot infection (DFI) and critical limb ischemia (CLI). Materials and Methods. The study group was composed of diabetic patients with DFI and CLI. All patients were treated according to a preset limb salvage protoco...
Saved in:
| Main Authors: | Marco Meloni, Valentina Izzo, Laura Giurato, Enrico Brocco, Michele Ferrannini, Roberto Gandini, Luigi Uccioli |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2019-01-01
|
| Series: | Journal of Diabetes Research |
| Online Access: | http://dx.doi.org/10.1155/2019/4312737 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The Effect of Charcot Neuroarthropathy on Limb Preservation in Diabetic Patients with Foot Wound and Critical Limb Ischemia after Balloon Angioplasty
by: Mehmet Burak Çildağ, et al.
Published: (2017-01-01) -
Procalcitonin and Diabetic Foot Ulcer Infections: A Meta‐Analysis
by: Wenqiang Wang, et al.
Published: (2025-07-01) -
Sympathectomy and Neuromodulation in the Treatment of Critical Lower Limb Ischemia
by: A. V. Yarikov, et al.
Published: (2022-04-01) -
Serum procalcitonin and procalcitonin clearance as a prognostic biomarker of sepsis in a pediatric critical care setting: A tertiary care experience 2016-2021.
by: Rattapon Uppala, et al.
Published: (2025-01-01) -
Cultivatable Bacteriota of Chronic Wound of Patients with Diabetic Foot Syndrome with Critical Limb Ischemia Based on Wound Biopsy in Peri-Revascularization Period
by: Syedah Sarah Hussaini, et al.
Published: (2025-01-01)